Possible alendronate-induced polyarticular synovitis
We present a case of polyarticular synovitis following alendronate treatment for osteoporosis. The patient had no evidence of rheumatoid arthritis, pyrophosphate arthropathy, or seronegative/seropositive arthritis. Our main aim in this study is to highlight the potential adverse effects of alendrona...
Main Authors: | K Gökkus, G Yazicioglu, E Sagtas, A Uyan, A T Aydin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Postgraduate Medicine |
Subjects: | |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2016;volume=62;issue=2;spage=126;epage=128;aulast= |
Similar Items
-
Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01) -
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study
by: Salvatore Minisola, et al.
Published: (2021-07-01) -
Oral bisphosphonates as the therapy of choice in patients with moderate risk of fractures
by: L. A. Marchenkova, et al.
Published: (2020-05-01) -
The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01) -
Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)